BML, Inc. (TYO:4694)
Japan · Delayed Price · Currency is JPY 3,520.00
+70.00 (2.03%)
Jun 3, 2026, 3:30 PM JST
BML, Inc. Market Cap
BML, Inc. has a market cap or net worth of 131.94 billion as of June 3, 2026. Its market cap has increased by 14.62% in one year.
Market Cap
131.94B
Enterprise Value
73.19B
Revenue
150.26B
Ranking
n/a
PE Ratio
17.30
Stock Price
3,520.00
Market Cap Chart
Since November 30, 1999, BML, Inc.'s market cap has increased from 54.98B to 131.94B, an increase of 139.98%. That is a compound annual growth rate of 3.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 131.94B | -8.81% |
| Dec 30, 2025 | 144.69B | 27.64% |
| Dec 30, 2024 | 113.35B | -3.08% |
| Dec 29, 2023 | 116.95B | -11.25% |
| Dec 30, 2022 | 131.77B | -9.09% |
| Dec 30, 2021 | 144.94B | 11.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.61T |
| HOYA Corporation | 8.85T |
| Takeda Pharmaceutical Company | 7.71T |
| Otsuka Holdings | 6.00T |
| Kaken Pharmaceutical | 147.50B |
| GNI Group | 143.51B |
| Takara Bio | 137.63B |
| PHC Holdings | 137.01B |